Found: 1
Select item for more details and to access through your institution.
Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study.
- Published in:
- Oncologist, 2012, v. 17, n. 7, p. 947, doi. 10.1634/theoncologist.2012-0048
- By:
- Publication type:
- Article